Boothbay Fund Management »

Ironwood Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Ironwood Pharmaceuticals shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.0M 3.1M 1.00
2023-06-30 $2.2M 2.2M 1.01

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr 1 3 Yr Treas Bd Put Option (SHY)
Vmware Cl A Com Call Option
Activision Blizzard
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Sarepta Therapeutics (SRPT)
Cornerstone Strategic Value (CLM)
Zimmer Holdings (ZBH)
Synopsys Put Option (SNPS)
Sprott Physical Gold & Silve Tr Unit (CEF)
Argenx Se Sponsored Adr (ARGX)
Select Sector Spdr Tr Indl Put Option (XLI)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Elanco Animal Health (ELAN)

View all positions for Boothbay Fund Management

Top funds holding Ironwood Pharmaceuticals

Capstone Investment Advisors
Balyasny Asset Management
Braidwell
Tenor Capital Management
Shenkman Capital Management
DLD Asset Management
Calamos Advisors
Jane Street
Worth Venture Partners
Jpmorgan Chase & Co
Bank of America Corporation
Citigroup
Virtus Investment Advisers
Arkadios Wealth Advisors

View all funds holding Ironwood Pharmaceuticals